These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11205462)

  • 61. The follicular non-Hodgkin's lymphomas--II. Prognostic factors: what do they mean?
    Denham JW; Denham E; Dear KB; Hudson GV
    Eur J Cancer; 1996 Mar; 32A(3):480-90. PubMed ID: 8814696
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of radiation therapy in the management of stage III follicular lymphomas.
    Paryani SB; Hoppe RT; Cox RS; Colby TV; Kaplan HS
    J Clin Oncol; 1984 Jul; 2(7):841-8. PubMed ID: 6376723
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment strategies in limited stage follicular NHL.
    Hoppe RT
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):179-86. PubMed ID: 21658617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic factors in primary gastric lymphoma.
    Medina-Franco H; Germes SS; Maldonado CL
    Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.
    Solal-Céligny P; Lepage E; Brousse N; Tendler CL; Brice P; Haïoun C; Gabarre J; Pignon B; Tertian G; Bouabdallah R; Rossi JF; Doyen C; Coiffier B
    J Clin Oncol; 1998 Jul; 16(7):2332-8. PubMed ID: 9667247
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
    Găman AM
    Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
    Karmali R; Kassar M; Venugopal P; Shammo JM; Fung HC; Bayer R; O'Brien T; Gregory SA
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):467-74. PubMed ID: 21700527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Can we cure indolent lymphomas?
    Cabanillas F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2655-9. PubMed ID: 10068269
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
    Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):783-91. PubMed ID: 26972651
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
    Wilder DD; Ogden JL; Jain VK
    Clin Lymphoma; 2002 Mar; 2(4):229-37. PubMed ID: 11970762
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
    Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO;
    Leuk Lymphoma; 2003 Nov; 44(11):1903-10. PubMed ID: 14738141
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
    Vose JM; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Chan WC; Greiner TC; Armitage JO
    J Clin Oncol; 1998 Mar; 16(3):844-9. PubMed ID: 9508164
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.
    Provencio M; Sabín P; Gomez-Codina J; Torrente M; Calvo V; Llanos M; Gumá J; Quero C; Blasco A; Cruz MA; Aguiar D; García-Arroyo F; Lavernia J; Martinez N; Morales M; Saez-Cusi A; Rodriguez D; de la Cruz L; Sanchez JJ; Rueda A;
    PLoS One; 2017; 12(5):e0177204. PubMed ID: 28493986
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diffuse large-cell lymphoma of the testis.
    Tondini C; Ferreri AJ; Siracusano L; Valagussa P; Giardini R; Rampinelli I; Bonadonna G
    J Clin Oncol; 1999 Sep; 17(9):2854-8. PubMed ID: 10561362
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Primary diffuse large B-cell non-Hodgkin's lymphoma of the small intestine: clinicopathologic features, management, and prognosis in 24 patients].
    Chen CQ; Yin L; Peng CH; Ye M; Zhao R; Chen GM; Zhou HJ; Li HW; Fan YZ
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):693-6. PubMed ID: 18246801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prolonged initial remission in patients with nodular mixed lymphoma.
    Longo DL; Young RC; Hubbard SM; Wesley M; Fisher RI; Jaffe E; Berard C; DeVita VT
    Ann Intern Med; 1984 May; 100(5):651-6. PubMed ID: 6370065
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.
    Peterson BA; Petroni GR; Frizzera G; Barcos M; Bloomfield CD; Nissen NI; Hurd DD; Henderson ES; Sartiano GP; Johnson JL; Holland JF; Gottlieb AJ
    J Clin Oncol; 2003 Jan; 21(1):5-15. PubMed ID: 12506163
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
    Sacchi S; Pozzi S; Marcheselli L; Bari A; Luminari S; Angrilli F; Merli F; Vallisa D; Baldini L; Brugiatelli M;
    Cancer; 2007 May; 109(10):2077-82. PubMed ID: 17394190
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
    Danieu L; Wong G; Koziner B; Clarkson B
    Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Long-term results with MACOP-B and radiation therapy for aggressive lymphomas].
    Krieger G; Kreysing E; Kneba M
    Onkologie; 2001 Feb; 24 Suppl 1():49-58. PubMed ID: 11441311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.